The dosages below are from completed studies on humans or on clinical trials on humans. In general, they represent safe dosages for most people. Please be aware that there is often an exponentail effectiveness. Talking half the dosage may only see 1/4 of the effect. We are not looking at minimum effective dosage, but maximum [safe] dosage used in clinical trials and studies.
If a study has been completed, the dosage will be marked Ineffective or Effective -- depending if statistically changes were reported by the study.
This is not medical advice (see your MD for that). It is a reporting on dosages that some MDs have used.
Look up dosages for other substances
| Study | Clinical Study | Dosage | Effective |
|---|---|---|---|
| . | Effects of Lactobacillus Casei on Respiratory and Gastrointestinal Diseases in Adults | 1000 mcfu/day | |
| . | Effect of Lactobacillus Casei DG (Enterolactis Plus®) in Patient With Irritable Bowel Syndrome: a Pilot Study | 48000 mcfu/day | |
| . | L. Casei DG® in Patients With Irritable Bowel Syndrome. (PROBE2) | 48000 mcfu/day | |
| . | Effect of Lactobacillus Casei Shirota on the Small Intestinal Microbiota (ROBIN) (ROBIN) | 6500 mcfu/day | |
| . | Effect of Glucomannan Supplementation on Body Weight in Overweight and Obese Children | 3000 mg/day | |
| . | Glucomannan Effects on Children With Non-alcoholic Fatty Liver Disease (GC-NASH) | 5000 mg/day | |
| . | Glucomannan for the Treatment of Abdominal Pain-related Functional Gastrointestinal Disorders in Childhood | 10000 mg/day |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.